Dynamics and determinants of the force of infection of dengue virus from 1994 to 2015 in Managua, Nicaragua

Proceedings of the National Academy of Sciences of the United States of America

Volumn 115, Issue 42, 2018, Pages 10762-10767

  Katzelnick, Leah C ^a   Ben Shachar, Rotem ^a   Mercado, Juan Carlos ^b,c   Rodriguez Barraquer, Isabel ^d   Elizondo, Douglas ^c   Arguello, Sonia ^c   Nuñez, Andrea ^b,c   Ojeda, Sergio ^c   Sanchez, Nery ^c   Mercado, Brenda Lopez ^c   Gresh, Lionel ^c   Burger Calderon, Raquel ^a,c   Kuan, Guillermina ^e   Gordon, Aubree ^f   Balmaseda, Angel ^b,c   Harris, Eva ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Ministry of Health   (Nicaragua)

^c Sustainable Sciences Institute   (Nicaragua)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Sócrates Flores Vivas Health Center   (Nicaragua)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cohort study; Dengue virus; Force of infection; Nicaragua; Transmission intensity

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; BLOOD; CHILD; DENGUE; DENGUE VIRUS; FEMALE; HEALTH SURVEY; HUMAN; ISOLATION AND PURIFICATION; MALE; NICARAGUA; PRESCHOOL CHILD; PROSPECTIVE STUDY; SEROEPIDEMIOLOGY; TIME FACTOR; TRANSMISSION; VIROLOGY;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; MALE; NICARAGUA; PROSPECTIVE STUDIES; PUBLIC HEALTH SURVEILLANCE; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS;

EID: 85054965106     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1809253115     Document Type: Article

References (35)

1. Bhatt S, et al. (2013) The global distribution and burden of dengue. Nature 496:504-507.
2. Katzelnick LC, Montoya M, Gresh L, Balmaseda A, Harris E (2016) Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort. Proc Natl Acad Sci USA 113:728-733.
3. Buddhari D, et al. (2014) Dengue virus neutralizing antibody levels associated with protection from infection in Thai cluster studies. PLoS Negl Trop Dis 8:e3230.
4. Halstead SB, O'Rourke EJ (1977) Dengue viruses and mononuclear phagocytes, I: Infection enhancement by non-neutralizing antibody. J Exp Med 146:201-217.
5. Halstead SB (1979) In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 140:527-533.
6. Katzelnick LC, et al. (2017) Antibody-dependent enhancement of severe dengue disease in humans. Science 358:929-932.
7. Hadinegoro SR, et al.; CYD-TDV Dengue Vaccine Working Group (2015) Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med 373: 1195-1206.
8. Halstead SB (2017) Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age. Vaccine 35:6355-6358.
9. SAGE Working Group on Dengue Vaccines and World Health Organization Secretariat (2016) Background paper on dengue vaccines prepared by the SAGE Working Group on Dengue (World Health Organization, Geneva).
10. Flasche S, et al. (2016) The long-term safety, public health impact, and costeffectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): A model comparison study. PLoS Med 13:e1002181.
11. Ferguson NM, et al. (2016) Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment. Science 353:1033-1036.
12. SAGE Working Group on Dengue Vaccines and World Health Organization Secretariat (2018) Background paper on dengue vaccines (World Health Organization, Geneva).
13. Ferguson NM, Donnelly CA, Anderson RM (1999) Transmission dynamics and epidemiology of dengue: Insights from age-stratified sero-prevalence surveys. Philos Trans R Soc Lond B Biol Sci 354:757-768.
14. Imai N, Dorigatti I, Cauchemez S, Ferguson NM (2015) Estimating dengue transmission intensity from sero-prevalence surveys in multiple countries. PLoS Negl Trop Dis 9: E0003719.
15. Imai N, Dorigatti I, Cauchemez S, Ferguson NM (2016) Estimating dengue transmission intensity from case-notification data from multiple countries. PLoS Negl Trop Dis 10: E0004833.
16. Rodriguez-Barraquer I, et al. (2011) From re-emergence to hyperendemicity: The natural history of the dengue epidemic in Brazil. PLoS Negl Trop Dis 5:e935.
17. Egger JR, et al. (2008) Reconstructing historical changes in the force of infection of dengue fever in Singapore: Implications for surveillance and control. Bull World Health Organ 86:187-196.
18. Cummings DAT, et al. (2009) The impact of the demographic transition on dengue in Thailand: Insights from a statistical analysis and mathematical modeling. PLoS Med 6: E1000139.
19. Rodríguez-Barraquer I, et al. (2014) Revisiting Rayong: Shifting seroprofiles of dengue in Thailand and their implications for transmission and control. Am J Epidemiol 179: 353-360.
20. Reiner RC, Jr, et al. (2014) Time-varying, serotype-specific force of infection of dengue virus. Proc Natl Acad Sci USA 111:E2694-E2702.
21. Kouri G, et al. (1991) [Dengue epidemic in Nicaragua, 1985]. Rev Inst Med Trop São Paulo 33:365-371. Spanish.
22. Guzmán MG, et al. (1996) [Dengue in Nicaragua, 1994: Reintroduction of serotype 3 in the Americas]. Bol Oficina Sanit Panam 121:102-110. Spanish.
23. Harris E, et al. (2000) Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg 63:5-11.
24. Brathwaite Dick O, et al. (2012) The history of dengue outbreaks in the Americas. Am J Trop Med Hyg 87:584-593.
25. United Nations Department of Economic and Social Affairs Population by age groups-Both sexes. Available at https://esa.un.org/unpd/wpp/Download/Standard/ Population/. Accessed July 22, 2016.
26. World Bank. Life expectancy at birth, total (years). Available at https://data.worldbank. org/indicator/SP.DYN.LE00.IN?end=2016&locations=NI. Accessed June 1, 2017.
27. World Bank. Birth rate, crude (per 1, 000 people), Nicaragua. Available at https://data. worldbank.org/indicator/SP.DYN.CBRT.IN?locations=NI. Accessed June 1, 2017.
28. Balmaseda A, et al. (2006) High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Int Health 11: 935-942.
29. Gordon A, et al. (2018) Differences in transmission and disease severity between two successive waves of chikungunya. Clin Infect Dis, 2-32.
30. Earn DJ, Rohani P, Bolker BM, Grenfell BT (2000) A simple model for complex dynamical transitions in epidemics. Science 287:667-670.
31. Kuan G, et al. (2009) The Nicaraguan Pediatric Dengue Cohort Study: Study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol 170:120-129.
32. Fernández RJ, Vázquez S (1990) Serological diagnosis of dengue by an ELISA inhibition method (EIM). Mem Inst Oswaldo Cruz 85:347-351.
33. Gutiérrez G, et al. (2013) Evaluation of the diagnostic utility of the traditional and revised WHO dengue case definitions. PLoS Negl Trop Dis 7:e2385.
34. Narvaez F, et al. (2011) Evaluation of the traditional and revised WHO classifications of dengue disease severity. PLoS Negl Trop Dis 5:e1397.
35. Nagao Y, Koelle K (2008) Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever. Proc Natl Acad Sci USA 105: 2238-2243.